Market Cap 2.92B
Revenue (ttm) 726.44M
Net Income (ttm) -61.29M
EPS (ttm) N/A
PE Ratio 22.45
Forward PE 21.41
Profit Margin -8.44%
Debt to Equity Ratio 0.00
Volume 3,180,200
Avg Vol 2,669,794
Day's Range N/A - N/A
Shares Out 166.39M
Stochastic %K 47%
Beta 0.37
Analysts Strong Sell
Price Target $24.95

Latest News on ACAD

Acadia Pharmaceuticals: Proving The Naysayers Wrong

Nov 11, 2024, 10:50 AM EST - 2 months ago

Acadia Pharmaceuticals: Proving The Naysayers Wrong


Ryan Reynolds Announces More to Parkinson's® Campaign

Aug 14, 2024, 8:04 AM EDT - 5 months ago

Ryan Reynolds Announces More to Parkinson's® Campaign


Acadia Pharmaceuticals: Back In The Buy Zone

Jun 23, 2024, 11:32 AM EDT - 7 months ago

Acadia Pharmaceuticals: Back In The Buy Zone


Acadia Appoints Elizabeth H. Z. Thompson, Ph.D.

Apr 2, 2024, 4:05 PM EDT - 10 months ago

Acadia Appoints Elizabeth H. Z. Thompson, Ph.D.


Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day

Mar 13, 2024, 4:05 PM EDT - 11 months ago

Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day


Acadia Pharma's stock falls 15% after failed drug trial

Mar 11, 2024, 5:01 PM EDT - 11 months ago

Acadia Pharma's stock falls 15% after failed drug trial